How to taper off Elavil (amitriptyline) in a patient taking 20mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Amitriptyline (Elavil) 20mg Daily

For a patient on amitriptyline 20mg daily, reduce the dose by 10% of the current dose every 2-4 weeks, which translates to approximately 2mg decrements initially, monitoring for withdrawal symptoms after each reduction before proceeding to the next step. 1

Recommended Tapering Schedule

  • Initial reduction: Decrease from 20mg to 18mg daily for 2-4 weeks 1
  • Subsequent reductions: Continue reducing by approximately 10% of the current dose (not the original dose) every 2-4 weeks 1
    • 18mg → 16mg → 14mg → 13mg → 11mg → 10mg, etc.
  • At lower doses: The reductions become smaller in absolute terms but maintain the same 10% relative reduction, which is critical to minimize withdrawal symptoms 2, 3
  • Final doses: Taper down to very small doses (1-2mg) before complete discontinuation rather than jumping off from a "minimum therapeutic dose" 2

Slower Tapering for Long-Term Use

  • If the patient has been on amitriptyline for years, use a much slower taper of 10% per month (or even slower) rather than every 2-4 weeks 1
  • Patients on long-term therapy require individualized, extended taper schedules based on their response and tolerance 1

Monitoring and Managing Withdrawal Symptoms

  • Watch for common withdrawal symptoms including dizziness, nausea, headache, paresthesia (tingling/numbness), irritability, anxiety, insomnia, and flu-like symptoms 4
  • After each dose reduction, monitor the patient for withdrawal symptoms before proceeding to the next step 1
  • If severe withdrawal symptoms occur: Return to the previous well-tolerated dose and slow the taper further by extending the time at each dose level to 4-8 weeks instead of 2-4 weeks 1, 4
  • For persistent insomnia: Consider short-term use of non-benzodiazepine sleep aids 1

Key Principles

  • Hyperbolic (exponential) tapering reduces the biological effect at receptors by fixed amounts, which minimizes withdrawal symptoms more effectively than linear dose reductions 2, 3
  • Gradual tapers over months show greater success in reducing withdrawal symptoms compared to the traditional 2-4 week tapers recommended in older guidelines 2
  • The first dose reduction is critical: It must be well-tolerated to establish confidence in the tapering process 5

Common Pitfalls to Avoid

  • Do not use traditional "short tapers" of 2-4 weeks down to half the therapeutic dose then stopping—these show minimal benefit over abrupt discontinuation 2
  • Do not mistake withdrawal symptoms for relapse of the underlying condition, which can lead to unnecessary reinitiation of medication 4
  • Do not use a "one-size-fits-all" rapid approach—slower is safer, especially for patients on long-term therapy 1, 6
  • Do not make equal absolute dose reductions (e.g., 5mg every 2 weeks)—use percentage-based reductions that become smaller as the total dose decreases 2, 3

References

Guideline

Citalopram Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Research

Antidepressant Tapering Is Not Routine But Could Be.

Journal of the American Board of Family Medicine : JABFM, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.